SCHEMBL6803016

SCHEMBL6803016

CN(C(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C)[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 18/20 0.57
CTSS P25774 2/20 0.47
CTSL P07711 1/20 0.47
CTSB P07858 1/20 0.47
CTSK P43235 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6804040 0.93 PTPRB (0.50) PTPRBCTSSCTSK
SCHEMBL6807810 0.90 PTPRB (0.53) PTPRB
SCHEMBL6807794 0.89 PTPRB (0.56) PTPRB
SCHEMBL6797357 0.88 PTPRB (0.49) PTPRB
SCHEMBL6803652 0.86 PTPRB (0.48) PTPRB
SCHEMBL6801847 0.86 PTPRB (0.64) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL6801845 0.86 PTPRB (0.64) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL6804439 0.85 PTPRB (0.55) PTPRB
SCHEMBL6808441 0.85 PTPRB (0.65) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL6808445 0.85 PTPRB (0.65) PTPRBCTSSCTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO claimed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US claimed
WO-2004074238-A1 PHENETHYLAMINO SULFAMIC ACIDS THE PROCTER & GAMBLE COMPANY (US) 2004-09-02 WO disclosed
US-20040167183-A1 Phenethylamino sulfamic acids THE PROCTER & GAMBLE COMPANY 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167183-A1 Phenethylamino sulfamic acids PTPRM, PTPRS, PTPRE PTPRB 13/4885CTSS 1861/4885CTSL 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.